About Dr. Jake N. Lichterman
Dr. Jake N. Lichterman is a medical oncologist and physician-scientist practicing in Dallas, Texas. His clinical work focuses particularly on cancers involving the urinary and reproductive systems, with kidney and bladder cancers among his principal areas of care.
He is an Instructor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He also treats patients through the Genitourinary Cancer Clinic at the Harold C. Simmons Comprehensive Cancer Center.
Dr. Lichterman combines clinical oncology with laboratory and translational research. His research interests include cancer immunotherapy, circadian rhythms, the gut microbiome, and factors that may influence how cancers respond to immune-based treatment.
Patients looking for other specialists can browse the Doctiplus doctor directory.
Focus Areas
- Kidney cancer
- Bladder cancer
- Genitourinary malignancies
- Medical oncology
- Systemic cancer treatment
- Immunotherapy
- Targeted cancer treatment
- Advanced or metastatic cancer
- Cancer treatment monitoring
- Treatment-related side-effect management
- Multidisciplinary oncology care
- Clinical and translational cancer research
Patients diagnosed with a renal tumour can review the National Cancer Institute’s information about kidney cancer, including established treatment approaches.
The NCI also provides patient information about bladder cancer. For patients considering immune-based treatments, its guide to cancer immunotherapy explains how these treatments work and why they are appropriate only for certain cancers and clinical situations.
Medical Oncology and Patient Care Approach
Medical oncology uses medicines to treat cancer. Depending on the diagnosis, treatment may include chemotherapy, immunotherapy, targeted medicines, or combinations of systemic therapies.
Dr. Lichterman’s clinical focus is genitourinary oncology. Treatment planning for kidney or bladder cancer may consider the tumour type, stage, pathology, molecular characteristics, previous treatment, kidney function, other medical conditions, and the patient’s overall health.
His research background is particularly focused on immunotherapy. Immune checkpoint inhibitors have become important treatments for several advanced cancers, but response differs from one patient to another. His research investigates biological factors that may influence this response.
Cancer treatment is commonly coordinated with urologists, radiation oncologists, radiologists, pathologists, and other specialists when multiple forms of treatment are required.
Education and Credentials
Dr. Jake Lichterman earned his Doctor of Osteopathic Medicine degree from Touro College of Osteopathic Medicine in New York in 2018.
He completed Internal Medicine residency training at UT Southwestern Medical Center and subsequently completed a Hematology and Oncology fellowship there in 2024 as part of the institution’s Physician Scientist Training Program.
He is certified by the American Board of Internal Medicine in both Internal Medicine and Medical Oncology. His professional associations include the Society for Immunotherapy of Cancer and the American Association for Cancer Research.
His National Provider Identifier is 1588167308.
Clinic Information
Dr. Lichterman currently sees patients through the Genitourinary Cancer Clinic at UT Southwestern’s Cancer Care Outpatient Building, 6202 Harry Hines Boulevard, Dallas, Texas 75235. UT Southwestern currently lists new-patient appointments and virtual visits for his practice.
Patients should confirm current consultation availability, referral requirements, accepted insurance, treatment services, and appointment arrangements directly with UT Southwestern before visiting.
Cardiologist
Reviews
There are no reviews yet.